Analysts at StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV – Get Rating) in a report released on Monday. The firm set a “hold” rating on the stock.
ObsEva Stock Performance
Shares of OBSV opened at $0.10 on Monday. The business’s 50-day moving average is $0.15 and its two-hundred day moving average is $0.16. ObsEva has a fifty-two week low of $0.08 and a fifty-two week high of $2.14. The company has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68.
Institutional Investors Weigh In On ObsEva
Institutional investors and hedge funds have recently modified their holdings of the company. Two Sigma Investments LP purchased a new position in shares of ObsEva in the 3rd quarter valued at about $25,000. Virtu Financial LLC acquired a new stake in shares of ObsEva during the first quarter worth $30,000. Pictet Asset Management SA increased its stake in shares of ObsEva by 25.8% during the 3rd quarter. Pictet Asset Management SA now owns 371,595 shares of the company’s stock valued at $53,000 after acquiring an additional 76,196 shares during the last quarter. XTX Topco Ltd raised its position in shares of ObsEva by 33.9% in the 1st quarter. XTX Topco Ltd now owns 79,757 shares of the company’s stock worth $120,000 after buying an additional 20,196 shares during the period. Finally, Millennium Management LLC acquired a new stake in ObsEva during the 2nd quarter worth approximately $192,000. Hedge funds and other institutional investors own 17.52% of the company’s stock.
About ObsEva
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.
Featured Articles
- Get a free copy of the StockNews.com research report on ObsEva (OBSV)
- MarketBeat Week in Review – 4/3 – 4/7
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here’s Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
Receive News & Ratings for ObsEva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ObsEva and related companies with MarketBeat.com's FREE daily email newsletter.
